Editorial
Published on 02 Dec 2022
Editorial: Insights in thoracic oncology: 2021/2022
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1089540
- 3,430 views
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,052 articles
Original Research
Published on 02 Dec 2022
Diagnostic value of dual-layer spectral detector CT in differentiating lung adenocarcinoma from squamous cell carcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.868216
- 2,772 views
- 9 citations
Case Report
Published on 01 Dec 2022
Case Report: A case of radioactive iodine-refractory thyroid cancer accompanying cervical lymph node metastasis treated with US-guided RFA combined with 125I seed implantation
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.987484
- 1,860 views
- 1 citation
Original Research
Published on 01 Dec 2022
Development and validation a simple scoring system to identify malignant pericardial effusion
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1012664
- 1,709 views
- 1 citation
Original Research
Published on 30 Nov 2022
The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1047019
- 2,227 views
- 6 citations
Original Research
Published on 29 Nov 2022
Immune checkpoint inhibitors alone or in combination with chemotherapy for treatment of advanced non-small cell lung cancer after first-line platinum-based chemotherapy: A propensity score matching analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.974227
- 2,081 views
Systematic Review
Published on 29 Nov 2022
Comparison of the efficacy and safety in the treatment strategies between chemotherapy combined with antiangiogenic and with immune checkpoint inhibitors in advanced non-small cell lung cancer patients with negative PD-L1 expression: A network meta-analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1001503
- 4,453 views
- 2 citations
Mini Review
Published on 29 Nov 2022
Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth?
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.996554
- 2,820 views
- 2 citations
Original Research
Published on 29 Nov 2022
Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 – 2020 - A population-based registry study from Norway
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1017902
- 2,500 views
- 4 citations
Systematic Review
Published on 28 Nov 2022
RT-based combination therapy for brain metastasis from NSCLC with non-EGFR mutation/ALK gene rearrangement: A network meta-analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1024833
- 2,641 views
- 2 citations
Case Report
Published on 25 Nov 2022
Case report: an initially unresectable stage III pulmonary sarcomatoid carcinoma qith EGFR mutation achieving pathological complete response following neoadjuvant therapy with osimertinib plus chemotherapy
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1033322
- 2,405 views
- 2 citations
Original Research
Published on 25 Nov 2022
Prognostic value and immune infiltration of the gasdermin family in lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1043862
- 3,193 views
- 12 citations
Original Research
Published on 24 Nov 2022
Machine-learning classifiers based on non-enhanced computed tomography radiomics to differentiate anterior mediastinal cysts from thymomas and low-risk from high-risk thymomas: A multi-center study
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1043163
- 1,841 views
- 10 citations
Review
Published on 22 Nov 2022
Non-genetic adaptive resistance to KRASG12C inhibition: EMT is not the only culprit
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.1004669
- 5,709 views
- 17 citations
Original Research
Published on 22 Nov 2022
Secondary preventing effect of lung cancer in non-high-risk population: A retrospective investigation of opportunistic screening with low-dose computed tomography in Wuhan
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.991485
- 1,745 views
- 1 citation
Original Research
Published on 21 Nov 2022
Clinical impact of number of lymph nodes dissected on postoperative survival in node-negative small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.962282
- 1,698 views
- 5 citations